Mintzer D, Henry D: FDA approvals in hematology and oncology, Part II: New oral formulations, RET and MET inhibitors, and CAR T-cell therapies MDEdge : 2021.
Mintzer D, Henry D: FDA approvals in hematology and oncology: Novel agents and new tricks for old drugs MDEdge : 2021.
Mintzer D: MKSAP 19, Oncology, Sections on lymphoma, melanoma, effects of cancer therapy and survivorship American College of Physicians : 2021.
Deye, DL; Mintzer D: MKSAP 19 Audio companion Oakstone : 2021.
Bryer E, Mintzer D, Henry DH: 2019 At a Glance: Hem-Onc U.S. Drug Approvals MDedge/Hematology and Oncology : 2019.
Emily Bryer, Monique Neault, David Mintzer: Managing Dying: Medical Care and Decision Making at the Very End-of-Life Palliative Medicine & Care: Open Access : DOI: http://dx.doi.org/10.15226/2374-8362/6/1/00180,2019.
Bryer E, Mintzer D, Henry D: 2018 At A Glance: Recently Approved Therapies in Oncology MD Edge/Hematology and Oncology : ://mdedge-files-live.s3.us-east-2.amazonaws.com,2019.
Deshields TL, Dueck AC, Rogers K, Brown JR, Shanafelt T, Mintzer D, Byrd JC: Perceived risk for cancer progression and psychological status in chronic lymphocytic leukemia patients: CALGB 70603 (Alliance). Leukemia and Lymphoma : 1-4,2019.
Mintzer D.: MKSAP Oncology, Sections on melanoma, lymphoma, survivorship/complications of chemotherapy ACP 17 : 2018.
Deye D, Mintzer D: ACP MKSAP 18 Audio Companion-- Oncology Oakstone : 2018.
Academic Contact Information
Abramson Cancer Center at Pennsylvania Hospital
Farm Journal Building
230 West Washington Square, 2nd Floor
Patient appointments: 800-789-7366